Alnylam Pharmaceuticals
ALNY
#438
Rank
$53.47 B
Marketcap
$404.74
Share price
0.07%
Change (1 day)
59.40%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company